Lv11
28 积分 2023-09-22 加入
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding
2小时前
待确认
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
11天前
已完结
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy
1个月前
已完结
Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index
2个月前
已完结
Precision Cuproptosis Activation via HER2‐Targeted Bimetallic MOF Nanoreactors Breaks Metabolic Adaptation in Aggressive Breast Cancers
2个月前
已完结
Synergistic SuFEx‐Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug
2个月前
已完结
Chemical Evolution of Double Covalent Aptamers for Sustained Protein Degradation and Improved Cytotoxicity in NK-Cell-Mediated Tumor Therapy
2个月前
已完结
Dimethyl itaconate attenuates IL-1-induced IVIG-resistant inflammation in a coronary artery cell model of Kawasaki disease
3个月前
已完结
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
3个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
3个月前
已完结
皖公网安备34019202002308
